These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9695698)

  • 21. Trends in prostate-specific antigen testing from 1995 through 2004.
    Farwell WR; Linder JA; Jha AK
    Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.
    Pilebro B; Johansson R; Damber L; Damber JE; Stattin P
    Scand J Urol Nephrol; 2003; 37(3):210-2. PubMed ID: 12775278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
    Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
    Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
    Farrell MH; Murphy MA; Schneider CE
    Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.
    Driscoll DL; Rupert DJ; Golin CE; McCormack LA; Sheridan SL; Welch BM; Poehlman JA
    Am J Prev Med; 2008 Aug; 35(2):87-94. PubMed ID: 18617077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receiver operating characteristics of the prostate specific antigen test in an unselected population.
    McLernon DJ; Donnan PT; Gray M; Weller D; Sullivan F
    J Med Screen; 2006; 13(2):102-7. PubMed ID: 16792835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.
    Welch HG; Schwartz LM; Woloshin S
    J Natl Cancer Inst; 2005 Aug; 97(15):1132-7. PubMed ID: 16077071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can a baseline prostate specific antigen level identify men who will have lower urinary tract symptoms later in life?
    Carter HB; Landis P; Wright EJ; Parsons JK; Metter EJ
    J Urol; 2005 Jun; 173(6):2040-3. PubMed ID: 15879821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public awareness of prostate cancer and the prostate-specific antigen test.
    Mainous AG; Hagen MD
    Cancer Pract; 1994; 2(3):217-21. PubMed ID: 7519944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-associated increase of prostate-specific antigen in a high level of men visiting urological clinics.
    Kobayashi T; Kinoshita H; Nishizawa K; Mitsumori K; Ogawa O; Kamoto T
    Int J Urol; 2005 Aug; 12(8):733-8. PubMed ID: 16174047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing use of the prostate-specific antigen screening test in primary care.
    Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
    Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioral associations between prostate and colon cancer screening.
    Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
    J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
    Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
    Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSA testing in general practice.
    Little B; Ho KJ; Gormley G; Young M
    Prostate Cancer Prostatic Dis; 2003; 6(2):154-8. PubMed ID: 12806375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey.
    Ross LE; Coates RJ; Breen N; Uhler RJ; Potosky AL; Blackman D
    Prev Med; 2004 Jun; 38(6):732-44. PubMed ID: 15193893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
    Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
    BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Awareness of the patients about detection of prostatic cancer].
    Rasner PI; Pushkar' DIu; Tsukanov AIu; Kupriianov IuA; Kalashian AA
    Urologiia; 2010; (2):47-51. PubMed ID: 20967995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.